@article{3119420,
    title = "Cardiac imaging in cardiotoxicity: a focus on clinical practice",
    author = "Makavos, G. and Ikonomidis, I. and Palios, J. and Rigopoulos, A. and Katogiannis, K. and Parissis, J. and Paraskevaidis, I. and Noutsias, M.",
    journal = "Heart Failure Reviews",
    year = "2021",
    volume = "26",
    number = "5",
    pages = "1175-1187",
    publisher = "Springer-Verlag",
    issn = "1382-4147",
    doi = "10.1007/s10741-020-09952-w",
    keywords = "(3 iodobenzyl)guanidine i 131;  anthracycline;  brain natriuretic peptide;  candesartan;  cisplatin;  contrast medium;  cyclophosphamide;  enalapril;  fluorodeoxyglucose f 18;  gadolinium;  imciromab pentetate;  nebivolol;  paclitaxel;  protein tyrosine kinase inhibitor;  razoxane;  recombinant vasculotropin;  rubidium 82;  trastuzumab;  troponin;  troponin I;  valsartan;  antineoplastic agent, cardiac dysfunction;  cardiac imaging;  cardiomyopathy;  cardiotoxicity;  cardiovascular magnetic resonance;  clinical practice;  coronary angiography;  diagnostic accuracy;  disease exacerbation;  echocardiography;  extracellular space;  global longitudinal strain;  glucose metabolism;  heart failure;  heart left ventricle ejection fraction;  heart muscle ischemia;  heart muscle perfusion;  heart protection;  human;  left ventricular global longitudinal strain;  lung artery pressure;  meta analysis (topic);  multigated radionuclide angiography;  myocardial perfusion imaging;  myocarditis;  non ST segment elevation myocardial infarction;  nonhuman;  nuclear magnetic resonance imaging;  radiation exposure;  reproducibility;  Review;  sensitivity and specificity;  single photon emission computed tomography;  speckle tracking echocardiography;  ST segment elevation myocardial infarction;  systolic function;  three dimensional echocardiography;  two dimensional echocardiography;  cardiotoxicity;  diagnostic imaging;  early cancer diagnosis;  heart;  heart disease;  heart left ventricle function, Antineoplastic Agents;  Cardiotoxicity;  Early Detection of Cancer;  Echocardiography;  Heart;  Heart Diseases;  Humans;  Ventricular Dysfunction, Left",
    abstract = "Cancer therapeutics induced cardiotoxicity has emerged as an important factor of long-term adverse cardiovascular outcomes in survivors of various malignant diseases. Early detection of myocardial injury in the setting of cancer treatment is important for the initiation of targeted cardioprotective therapy, in order to prevent irreversible cardiac dysfunction and heart failure, while not withholding a potentially life-saving cancer therapy. Cardiac imaging techniques including echocardiography, cardiac magnetic resonance, and nuclear cardiac imaging are the main tools for the identification of cardiotoxicity. There is also growing evidence for the detection of subclinical cardiac dysfunction in cancer patients by speckle tracking echocardiography. In this review article, we focus on current and emerging data regarding the role of cardiac imaging for the detection of changes in myocardial function related with cancer treatment in clinical practice. © 2020, Springer Science+Business Media, LLC, part of Springer Nature."
}